CYTOCHALASIN B is a lipid of Polyketides (PK) class. Cytochalasin b is associated with abnormalities such as Renal tubular disorder and Chagas Disease. The involved functions are known as Membrane Protein Traffic, inhibitors, Metabolic Inhibition, Biochemical Pathway and Increased Sensitivy. Cytochalasin b often locates in Cytoplasmic matrix, Plasma membrane, Microtubules, Extracellular and Protoplasm. The associated genes with CYTOCHALASIN B are SLC2A2 gene, PFDN5 gene, SLC2A1 gene, OMG gene and SPEN gene. The related lipids are Steroids, Lipopolysaccharides and Liposomes. The related experimental models are Xenograft Model.
To understand associated biological information of CYTOCHALASIN B, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
CYTOCHALASIN B is suspected in Renal tubular disorder, Chagas Disease and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with CYTOCHALASIN B
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Xenograft Model are used in the study 'Endofacial competitive inhibition of the glucose transporter 1 activity by gossypol.' (Pérez A et al., 2009).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Misselwitz F et al. | Substances that polymerize or depolymerize cytoskeletal proteins affect platelet spreading and thrombus-formation on surfaces coated with human collagen isotypes I, IV, and V. | 1988 | Thromb. Res. | pmid:3413723 |
Patscheke H and Wörner P | Sequential effects of the thiol-oxidizing agent, diamide, on human platelets. | 1978 | Thromb. Res. | pmid:663899 |
Rendu F and Lebret M | Interaction of wheat germ agglutinin with human platelets: a model for studying platelet response. | 1984 | Thromb. Res. | pmid:6441308 |
Haslam RJ and Lynham JA | Relationship between phosphorylation of blood platelet proteins and secretion of platelet granule constituents II. Effects of different inhibitors. | 1978 | Thromb. Res. | pmid:208190 |
Markosian RA and Kozlov VK | A study of transformations of blood platelets intracellular granules during clot formation by means of fluorescent marker method. | 1980 | Thromb. Res. | pmid:7189908 |
Patscheke H et al. | The relationship between shape change and release reaction of lectin-stimulated platelets. Effects of cytochalasin B and prostaglandin E1. | 1977 | Thromb. Res. | pmid:854880 |
Mitsui-Saito M et al. | Theonezolide A, a novel marine macrolide, induces drastic shape change in rabbit platelets by reorganization of microtubules. | 2002 | Thromb. Res. | pmid:12590949 |
Goto S et al. | Thrombin-induced shape change in human megakaryoblastic leukemic cells, MEG-01, is mediated by protein kinase C. | 1992 | Thromb. Res. | pmid:1448800 |
Patscheke H and Wörner P | Common activation of aggregation and released reaction of platelets. | 1977 | Thromb. Res. | pmid:411193 |
Patscheke H and Wörner P | Platelet activation detected by turbidometric shape-change analysis: differential influence of cytochalasin B and prostaglandin E1. | 1978 | Thromb. Res. | pmid:418518 |